Connecticut-based start-up, Neuvotion, has raised $1.25 million in funding from Northwell Holdings to develop innovative solutions for restoring movement in patients with disabilities or injuries. Neuvotion is a medical equipment manufacturing company that specializes in combining neurostimulation with artificial intelligence to deliver unprecedented therapeutic value to patients with movement disorders.

By leveraging cutting-edge technology, Neuvotion offers doctors and therapists the ability to monitor patient progress remotely or in person, which allows for more personalized and effective treatments. Neuvotion's products have the potential to revolutionize movement therapy for patients who suffer from disabilities or impairments resulting from strokes or injuries.

The company's mission is to empower patients with the tools and resources needed to achieve a higher level of mobility and independence. With this latest funding round, Neuvotion is well-positioned to continue its research and development efforts and bring its innovative products to market.

Northwell Holdings, one of the investors in this funding round, is a venture capital firm that focuses on investing in companies that have the potential to transform the healthcare industry.

This partnership between Neuvotion and Northwell Holdings is a significant step towards revolutionizing the movement therapy industry and improving the lives of patients who suffer from movement disorders. Visit us for more information about their latest funding round: https://founderlodge.com/round/Neuvotion-Inc-raises-1250000-Unknown-2023-04-14-Chad-Bouton-MTIxOTE